Ascentage Pharma Group Internat (AAPG) Q2 2026 earnings — TrendMatrix coverage
IN LINEEPS — vs — estVerdict Hold → Buy (Wait)
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
Key numbers
- Adjusted EPS
- —
- Estimate
- —
- Surprise
- —
- Score at report (before → after)
- 6.6 → 6.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Report record · Q2 2026
How the report landed
TrendMatrix's engine moved from Hold (6.6/10) to Buy (Wait) at 6.7/10 after the report.